Human apolipoprotein C-I expression in mice impairs learning and memory functions

Journal of Lipid Research

Volumn 49, Issue 4, 2008, Pages 856-869

  Abildayeva, Karlygash ^a   Berbée, Jimmy F P ^b,c   Blokland, Arjan ^b   Jansen, Paula J ^a   Hoek, Frans J ^d   Meijer, Onno ^e   Lütjohann, Dieter ^g   Gautier, Thomas ^f   Pillot, Thierry ^h   De Vente, Jan ^a   Havekes, Louis M ^b   Ramaekers, Frans C S ^a,b   Kuipers, Folkert ^f   Rensen, Patrick C N ^c   Mulder, Monique ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITÉ DE LORRAINE   (France)

Author keywords

amyloid; Alzheimer's disease; Apolipoprotein E; Morris water maze task; Object recognition task

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; CAMPESTEROL; CHOLESTANOL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; DESMOSTEROL; LANOSTEROL; LATHOSTEROL; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; SITOSTEROL; SPHINGOMYELIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN C I, HUMAN; APOLIPOPROTEIN C-I, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN LEVEL; CELL VIABILITY; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIUM CELL; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEARNING DISORDER; LIPID METABOLISM; MAZE TEST; MEMORY DISORDER; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RECOGNITION; TASK PERFORMANCE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; METABOLISM; TISSUE CULTURE TECHNIQUE;

ANIMALS; APOLIPOPROTEIN C-I; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RNA, MESSENGER; TISSUE CULTURE TECHNIQUES;

EID: 44949262269     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700518-JLR200     Document Type: Article

References (80)

1. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261: 921-923.
2. Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. George- Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. Crapper-MacLachlan, M. J. Alberts, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43: 1467-1472.
3. St. George-Hyslop, P. H. 2000. Molecular genetics of Alzheimer's disease. Biol. Psychiatry. 47: 183-199.
4. Lauer, S. J., D. Walker, N. A. Elshourbagy, C. A. Reardon, B. Levy- Wilson, and J. M. Taylor. 1988. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263: 7277-7286.
5. Xu, Y., L. Berglund, R. Ramakrishnan, R. Mayeux, C. Ngai, S. Holleran, B. Tycko, T. Leff, and N. S. Shachter. 1999. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J. Lipid Res. 40: 50-58.
6. Kamino, K., A. Yoshiiwa, Y. Nishiwaki, K. Nagano, H. Yamamoto, T. Kobayashi, Y. Nonomura, H. Yoneda, T. Sakai, M. Imagawa, et al. 1996. Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster. Gerontology. 42(Suppl. 1): 12-19.
7. Mullan, M., P. Scibelli, R. Duara, D. Fallin, M. Gold, J. Schinka, J. Hoyne, A. Osborne, S. Sevush, and F. Crawford. 1996. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann. N. Y. Acad. Sci. 802: 16-26.
8. Poduslo, S. E., M. Neal, K Herring, and J. Shelly. 1998. The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem. Res. 23: 361-367.
9. Poduslo, S. E., M. Neal, and J. Schwankhaus. 1995. A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease. Neurosci. Lett. 201: 81-83.
10. Scacchi, R., G. Gambina, M. Ruggeri, M. C. Martini, G. Ferrari, M. Silvestri, R. Schiavon, and R. M. Corbo. 1999. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci. Lett. 259: 33-36.
11. Schellenberg, G. D., M. Boehnke, E. M. Wijsman, D. K Moore, G. M. Martin, and T. D. Bird. 1992. Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's disease. Ann. Neurol. 31: 223-227.
12. Bertram, L., M. B. McQueen, K. Mullin, D. Blacker, and R. E. Tanzi. 2007. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39: 17-23.
13. Bartres-Faz, D., C. Junque, I. C. Clemente, J. M. Serra-Grabulosa, J. Guardia, A. Lopez-Alomar, J. Sanchez-Aldeguer, J. M. Mercader, N. Bargallo, M. Olondo, et al. 2001. MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol. Aging. 22: 449-459.
14. Serra-Grabulosa, J. M., P. Salgado-Pineda, C. Junque, C. Sole- Padulles, P. Moral, A. Lopez-Alomar, T. Lopez, A. Lopez-Guillen, N. Bargallo, J. M. Mercader, et al. 2003. Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics. 4: 141-146.
15. Chartier-Harlin, M. C., M. Parfitt, S. Legrain, J. Perez-Tur, T. Brousseau, A. Evans, C. Berr, O. Vidal, P. Roques, V. Gourlet, et al. 1994. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3: 569-574.1
16. Drigalenko, E., S. Poduslo, and R. Elston. 1998. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology. 51: 131-135.
17. de Knijff, P., and C. M. van Duijn. 1998. Role of APOE in dementia: a critical reappraisal. Haemostasis. 28: 195-201.
18. van der Hoogt, C. C., J. F. Berbee, S. M. Espirito Santo, G. Gerritsen, Y. D. Krom, A. van der Zee, L. M. Havekes, K. W. van Dijk, and P. C. Rensen. 2006. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apo- lipoprotein CIII in mice. Biochim. Biophys. Acta. 1761: 213-220.
19. Jong, M. C., V. E. Dahlmans, P. J. van Gorp, K. W. van Dijk, M. L. Breuer, M. H. Hofker, and L. M. Havekes. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98: 2259-2267.
20. Jong, M. C., M. J. Gijbels, V. E. Dahlmans, P. J. Gorp, S. J. Koopman, M. Ponec, M. H. Hofker, and L. M. Havekes. 1998. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J. Clin. Invest. 101: 145-152.
21. Jong, M. C., M. H. Hofker, and L. M. Havekes. 1999. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
22. Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267.
23. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta- VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459.
24. Havel, R. J., C. J. Fielding, T. Olivecrona, V. G. Shore, P. E. Fielding, and T. Egelrud. 1973. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources. Biochemistry. 12: 1828-1833.
25. Berbee, J. F., C. C. van der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. Rensen. 2005. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J. Lipid Res. 46: 297-306.
26. Lukiw, W. J., M. Pappolla, R. P. Pelaez, and N. G. Bazan. 2005. Alzheimer's disease-a dysfunction in cholesterol and lipid metabolism. Cell. Mol. Neurobiol. 25: 475-483.
27. Reiss, A. B. 2005. Cholesterol and apolipoprotein E in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 20: 91-96.
28. Alessandri, J. M., P. Guesnet, S. Vancassel, P. Astorg, I. Denis, B. Langelier, S. Aid, C. Poumes-Ballihaut, G. Champeil-Potokar, and M. Lavialle. 2004. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 44: 509-538.
29. Lane, R. M., and M. R. Farlow. 2005. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J. Lipid Res. 46: 949-968.
30. Poirier, J. 2005. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol. Aging. 26: 355-361.
31. Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42: 1097-1105.
32. Somogyi, P., and H. Takagi. 1982. A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry. Neuroscience. 7: 1779-1783.
33. Meijer, O. C., P. J. Steenbergen, and E. R. De Kloet. 2000. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology. 141: 2192-2199.
34. Jong, M. C., J. H. van Ree, V. E. Dahlmans, R. R. Frants, M. H. Hofker, and L. M. Havekes. 1997. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice. Biochem. J. 321: 445-450.
35. Blokland, A., E. Geraerts, and M. Been. 2004. A detailed analysis of rats' spatial memory in a probe trial of a Morris task. Behav. Brain Res. 154: 71-75.
36. Sevre, K., J. D. Lefrandt, G. Nordby, I. Os, M. Mulder, R. O. Gans, M. Rostrup, and A. J. Smit. 2001. Autonomic function in hypertensive and normotensive subjects: the importance of gender. Hypertension. 37: 1351-1356.
37. Weerheim, A. M., A. M. Kolb, A. Sturk, and R. Nieuwland. 2002. Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal. Biochem. 302: 191-198.
38. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
39. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994.
40. Plosch, T., T. Kok, V. W. Bloks, M. J. Smit, R. Havinga, G. Chimini, A. K. Groen, and F. Kuipers. 2002. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J. Biol. Chem. 277: 33870-33877.
41. LeVine, H., 3rd. 1993. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2: 404-410.
42. Pillot, T., L. Lins, M. Goethals, B. Vanloo, J. Baert, J. Vandekerckhove, M. Rosseneu, and R. Brasseur. 1997. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol. 274: 381-393.
43. Pillot,T.,M.Goethals,B.Vanloo,L.Lins,R.Brasseur,J. Vandekerckhove, and M. Rosseneu. 1997. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms. Eur. J. Biochem. 243: 650-659.
44. Fifre, A., I. Sponne, V. Koziel, B. Kriem, F. T. Yen Potin, B. E. Bihain, J. L. Olivier, T. Oster, and T. Pillot. 2006. Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3. J. Biol. Chem. 281: 229-240.
45. Kriem, B., I. Sponne, A. Fifre, C. Malaplate-Armand, K. Lozac'h-Pillot, V. Koziel, F. T. Yen-Potin, B. Bihain, T. Oster, J. L. Olivier, and T. Pillot. 2005. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J. 19: 85-87.
46. Mazzetti, S., S. Frigerio, M. Gelati, A. Salmaggi, and L. Vitellaro- Zuccarello. 2004. Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system. Eur. J. Histochem. 48: 423-428.
47. Rofina, J., I. van Andel, A. M. van Ederen, N. Papaioannou, H. Yamaguchi, and E. Gruys. 2003. Canine counterpart of senile dementia of the Alzheimer type: amyloid plaques near capillaries but lack of spatial relationship with activated microglia and macrophages. Amyloid. 10: 86-96.
48. Champeil-Potokar, G., I. Denis, B. Goustard-Langelier, J. M. Alessandri, P. Guesnet, and M. Lavialle. 2004. Astrocytes in culture require docosahexaenoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids. J. Neurosci. Res. 75: 96-106.
49. Bourre, J. M., G. Pascal, G. Durand, M. Masson, O. Dumont, and M. Piciotti. 1984. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem. 43: 342-348.
50. Bourre, J. M., M. Bonneil, J. Chaudiere, M. Clement, O. Dumont, G. Durand, H. Lafont, G. Nalbone, G. Pascal, and M. Piciotti. 1992. Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system. Adv. Exp. Med. Biol. 318: 211-229.
51. Oitzl,M. S.,M.Mulder, P.J.Lucassen, L.M. Havekes,J. Grootendorst, and E. R. de Kloet. 1997. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752: 189-196.
52. Zhou, Y., P. D. Elkins, L. A. Howell, D. H. Ryan, and R. B. Harris. 1998. Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice. Brain Res. 788: 151-159.
53. Grootendorst, J., E. R. de Kloet, S. Dalm, and M. S. Oitzl. 2001. Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience. Neuroscience. 108: 237-247.
54. Gordon, I., E. Grauer, I. Genis, E. Sehayek, and D. M. Michaelson. 1995. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199: 1-4.
55. Ki, C. S., D. L. Na, D. K. Kim, H. J. Kim, andJ. W. Kim. 2002. Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease. Neurosci. Lett. 319: 75-78.
56. Petit-Turcotte, C., S. M. Stohl, U. Beffert, J. S. Cohn, N. Aumont, M. Tremblay, D. Dea, L. Yang, J. Poirier, and N. S. Shachter. 2001. Apolipoprotein C-I expression in the brain in Alzheimer's disease. Neurobiol. Dis. 8: 953-963.
57. Wisniewski, T., A. A. Golabek, E. Kida, K. E. Wisniewski, and B. Frangione. 1995. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am. J. Pathol. 147: 238-244.
58. Youssef, I., S. Florent-Bechard, C. Malaplate-Armand, V. Koziel, B. Bihain, J. L. Olivier, B. Leininger-Muller, B. Kriem, T. Oster, and T. Pillot. 2008. N-Truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis. Neurobiol. Aging. In press.
59. LaDu, M. J., J. R. Lukens, C. A. Reardon, and G. S. Getz. 1997. Association of human, rat, and rabbit apolipoprotein E with beta- amyloid. J. Neurosci. Res. 49: 9-18.
60. Iivonen, H., L. Nurminen, M. Harri, H. Tanila, and J. Puolivali. 2003. Hypothermia in mice tested in Morris water maze. Behav. Brain Res. 141: 207-213.
61. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
62. Pfrieger, F. W. 2003. Role of cholesterol in synapse formation and function. Biochim. Biophys. Acta. 1610: 271-280.
63. Pfrieger, F. W. 2003. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes? Bioessays. 25: 72-78.
64. Pfrieger, F. W. 2003. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 60: 1158-1171.
65. Jansen, P. J., D. Lutjohann, K. Abildayeva, T. Vanmierlo, T. Plosch, J. Plat, K. von Bergmann, A. K. Groen, F. C. Ramaekers, F. Kuipers, et al. 2006. Dietary plant sterols accumulate in the brain. Biochim. Biophys. Acta. 1761: 445-453.
66. Vilaro, S., L. Camps, M. Reina, J. Perez-Clausell, M. Llobera, and T. Olivecrona. 1990. Localization of lipoprotein lipase to discrete areas of the guinea pig brain. Brain Res. 506: 249-253.
67. Blain, J. F., E. Paradis, S. B. Gaudreault, D. Champagne, D. Richard, and J. Poirier. 2004. A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain. Neurobiol. Dis. 15: 510-519.
68. Paradis, E., S. Clavel, P. Julien, M. R. Murthy, F. de Bilbao, D. Arsenijevic, P. Giannakopoulos, P. Vallet, and D. Richard. 2004. Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia. Neurobiol. Dis. 15: 312-325.
69. Huey, P. U., K. C. Waugh, J. Etienne, and R. H. Eckel. 2002. Lipoprotein lipase is expressed in rat sciatic nerve and regulated in response to crush injury. J. Lipid Res. 43: 19-25.
70. Postuma, R. B., R. N. Martins, R. Cappai, K. Beyreuther, C.L. Masters, D. K Strickland, S. S. Mok, and D. H. Small. 1998. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor-related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett. 428: 13-16.
71. Paradis, E., S. Clement, P. Julien, and M. R. Ven Murthy. 2003. Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein. J. Biol. Chem. 278: 9698-9705.
72. Paradis, E., P. Julien, and M. R. Ven Murthy. 2004. Requirement for enzymatically active lipoprotein lipase in neuronal differentiation: a site-directed mutagenesis study. Brain Res. Dev. Brain Res. 149: 29-37.
73. Mak, P. A., B. A. Laffitte, C. Desrumaux, S. B. Joseph, L. K. Curtiss, D. J. Mangelsdorf, P. Tontonoz, and P. A. Edwards. 2002. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. Acritical role for nuclear liver X receptors alpha and beta. J. Biol. Chem. 277: 31900-31908.
74. Castrillo, A., and P. Tontonoz. 2004. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 20: 455-480.
75. Ulven, S. M., K. T. Dalen, J. A. Gustafsson, and H. I. Nebb. 2005. LXR is crucial in lipid metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 73: 59-63.
76. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116:607-614.
77. Whitney, K. D., M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J.Numerick,T.K.Tippin, J. G. Wilson, D. A. Winegar, and S.A. Kliewer. 2002. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16: 1378-1385.
78. Abildayeva, K., P. J. Jansen, V. Hirsch-Reinshagen, V. W. Bloks, A. H. Bakker, F. C. Ramaekers, J. de Vente, A. K. Groen, C. L. Wellington, F. Kuipers, et al. 2006. 24(S)-Hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281: 12799-12808.
79. Berbee, J. F., C. C. van der Hoogt, R. Kleemann, E. F. Schippers, R. L. Kitchens, J. T. van Dissel, I. A. Bakker-Woudenberg, L. M. Havekes, and P. C. Rensen. 2006. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram-negative sepsis. FASEB J. 20: 2162-2164.
80. Drouet, B., A. Fifre, M. Pincon-Raymond, J. Vandekerckhove, M. Rosseneu, J. L. Gueant, J. Chambaz, and T. Pillot. 2001. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide. J. Neurochem. 76: 117-127.